The Most Important Business Trend In Pharma
In the midst of a political season that’s slapped a target on biopharma’s back, public frustration with high drug prices has become palpable. Add to that persistent media coverage of controversial price hikes by companies like Valeant Pharmaceuticals VRX -4.13% , and tempers have maintained a slow boil.